Lupin Somerset facility gets EIR from USFDA Rahul Verma9 July 2022 6:30 PM ISTGlobal pharma major, Lupin Limited, today announced that the company has received the Establishment Inspection Report (EIR) from United States Food...
Lupin gets USFDA EIR for Somerset facility Ruchika Sharma7 July 2022 11:30 AM ISTThe USFDA has determined that the inspection classification of the facility is Voluntary Action Indicated (VAI).
Lupin gets USFDA nod for generic equivalent of Invega ER Tablets Ruchika Sharma1 July 2022 12:30 PM ISTThe product will be manufactured at Lupin’s facility in Goa, India.
Lupin, Accenture collaborate to accelerate business efficacy with data driven competencies Ruchika Sharma20 Jun 2022 1:30 PM IST"SAP Fiori apps have helped enhance the user experience for Lupin employees with simple and easy-to access data models and analytical reports," the...
Lupin Diagnostics opens Regional Reference Laboratory in Patna Ruchika Sharma15 Jun 2022 4:53 PM IST"By establishing a presence in Patna, the company now looks forward to making a deeper foray into Bihar," the company said.
Lupin bags USFDA nod for cystic fibrosis drug Ivacaftor Ruchika Sharma8 Jun 2022 2:47 PM ISTThis product will be manufactured at Lupin’s Nagpur facility in India.
Glenmark, Dr Reddys and 2 others recall products in US Ruchika Sharma16 May 2022 2:19 PM ISTNew Delhi: Homegrown drug majors Lupin, Glenmark and Dr Reddy's Laboratories are recalling different products in the US, the world's largest market...
USFDA nod to Lupin Iloperidone tablets Ruchika Sharma7 May 2022 12:36 PM ISTMumbai: Lupin Limited has recently announced that the company has received approval from the United States Food and Drug Administration (USFDA) for...
Lupin gets USFDA nod for generic equivalent of Lyrica Capsules Ruchika Sharma7 May 2022 11:25 AM ISTPregabalin is used for the treatment of pain caused by nerve damage due to diabetes or shingles infection.
Huntington's disease drug: Teva Pharma settles patent dispute with Lupin, continues to litigate against Aurobindo Ruchika Sharma3 May 2022 4:05 PM ISTUnder the terms of the settlement agreement, Lupin will have a license to sell its generic product beginning April 2033, or earlier under certain...
Lupin Diagnostics unveils reference lab in Guwahati Ruchika Sharma30 April 2022 11:24 AM ISTAfter Assam and West Bengal, Lupin Diagnostics is also setting up laboratories in Bihar, Jharkhand and Orrisa to comprehensively cater to eastern...
Lupin, Yabao Pharma collaborate to meet growing demand for pediatric formulations in China Ruchika Sharma28 April 2022 12:34 PM ISTMumbai: Global pharma major Lupin Limited has announced that the company has entered into a strategic partnership with Yabao Pharmaceutical Co. Inc.,...
